Skip to main content

EDITORIAL article

Front. Cell Dev. Biol.
Sec. Signaling
Volume 12 - 2024 | doi: 10.3389/fcell.2024.1467372
This article is part of the Research Topic Myc as a Disease Target Beyond Cancer View all 16 articles

Editorial for Research Topic: MYC as a disease target beyond cancer

Provisionally accepted
Jonathan R. Whitfield Jonathan R. Whitfield *
  • Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

The final, formatted version of the article will be published soon.

    Keywords: MYC, targeting, transcription factor, non-oncologic diseases, therapy

    Received: 19 Jul 2024; Accepted: 31 Jul 2024.

    Copyright: © 2024 Whitfield. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Jonathan R. Whitfield, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.